Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Accured Expenses (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Change in Accured Expenses data on record, last reported at $729000.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 207.68% year-over-year to $729000.0; the TTM value through Sep 2025 reached -$846000.0, up 52.71%, while the annual FY2024 figure was -$1.5 million, 5.77% down from the prior year.
  • Change in Accured Expenses reached $729000.0 in Q3 2025 per UTMD's latest filing, up from -$1.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.4 million in Q3 2022 and bottomed at -$1.9 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is -$145421.1, with a median of -$98000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: plummeted 1536.36% in 2021, then surged 207.68% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$98000.0 in 2021, then tumbled by 739.8% to -$823000.0 in 2022, then soared by 60.02% to -$329000.0 in 2023, then soared by 86.63% to -$44000.0 in 2024, then skyrocketed by 1756.82% to $729000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $729000.0 in Q3 2025, -$1.9 million in Q2 2025, and $360000.0 in Q1 2025.